Duration: A Multicenter Randomized Phase II Trial Investigating Sequential Mono- (Mctx) Or Doublet-Chemotherapy (Dctx) Followed By Durvalumab (D) In Older Or Frail Patients With Advanced Non-Small Cell Lung Cancer (Nsclc)
Durvalumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Duration: A Multicenter Randomized Phase II Trial Investigating Sequential Mono- (Mctx) Or Doublet-Chemotherapy (Dctx) Followed By Durvalumab (D) In Older Or Frail Patients With Advanced Non-Small Cell Lung Cancer (Nsclc) ### Output: Durvalumab